Shopping Cart 0
Cart Subtotal
AED 0

Koninklijke Philips N.V. (PHIA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 2753

Details

Summary

Koninklijke Philips N.V. (Philips) is a diversified technology company develops and manufactures medical systems, consumer electronics and lighting products. The company offers patient care & clinical informatics, imaging systems, healthcare transformation services and home healthcare solutions. It also offers mother and child care, and oral healthcare products include male grooming and beauty products kitchen appliance, coffee, air, garment care, and floor care products and sleep, respiratory care, and respiratory drug delivery products. It also provides diagnostic x-ray, integrated clinical, magnetic resonance imaging, computed tomography, and molecular imaging solutions. The company provides health & wellness, personal care and domestic appliances. Philips offers consumer luminaires, lumileds, professional lighting solutions, light sources & electronics and automotive lighting. It has operational presence in both mature and growth geographies. The company caters to Healthcare, Consumer Life Style, and Lighting industries. Philips is headquartered in Amsterdam, the Netherlands.

Koninklijke Philips N.V. (PHIA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Koninklijke Philips N.V., Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Koninklijke Philips N.V., Medical Devices Deals, 2012 to YTD 2018 10

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deal Details 13

Venture Financing 13

Biocartis Raises USD 40.5 Million In Series E Financing 13

NightBalance Raises Funds in Second Round of Financing 15

NightBalance Raises Funds Through Venture Financing 16

Biocartis Raises USD 44.7 Million In Series D Financing 17

Partnerships 19

Royal Philips and Memorial Sloan Kettering Cancer Center Enter into Research Agreement 19

Koninklijke Philips Enters into Agreement with Illumina 20

Ion Beam Applications Enters into Agreement with Philips Healthcare 21

Royal Philips Enters into Agreement with Universitaire Ziekenhuizen Leuven 22

Ion Beam Applications Enters into Co-Development Agreement with Royal Philips 23

Teva Pharma Industries to Form Joint Venture with Philips Medical Systems 24

Debt Offering 25

Royal Philips Prices Public Offering of Notes Due 2019 for USD596.6 Million 25

Royal Philips Prices Public Offering of Notes Due 2023 for USD596.6 Million 26

Acquisition 27

Philips to Acquire Unisensor, Analytical Instrument Provider 27

Zambon Acquires Profile Pharma from Philips 28

Volcano Completes Acquisition Of Crux Biomedical, Developer Of Implantable Filter, For Up To USD 42.1 Million 29

Koninklijke Philips N.V.-Key Competitors 32

Koninklijke Philips N.V.-Key Employees 33

Koninklijke Philips N.V.-Locations And Subsidiaries 34

Head Office 34

Other Locations & Subsidiaries 34

Joint Venture 37

Recent Developments 38

Strategy And Business Planning 38

Aug 24, 2017: Governor Haslam, Commissioner Rolfe Announce Philips to Establish Business Center of Expertise in Middle Tennessee 38

Financial Announcements 39

Jul 23, 2018: Philips reports Second Quarter Results 2018 39

Apr 23, 2018: Philips First Quarter Results 2018 41

Jan 30, 2018: Philips' Fourth Quarter and Annual Results 2017 43

Oct 23, 2017: Philips' Third Quarter Results 2017 46

Jul 24, 2017: Philips' Second Quarter Results 2017 48

Corporate Communications 51

Oct 20, 2017: Extraordinary General Meeting of Shareholders appoints Marnix van Ginneken to Philips' Board of Management 51

Sep 18, 2017: Philips Steps Up Commitment to Ensuring Healthy Lives for All During United Nations General Assembly Week 52

Jul 20, 2017: Chief Business Leader of Philips' Personal Health businesses Pieter Nota to leave company 53

Government and Public Interest 54

Nov 23, 2017: Philips-led research consortium awarded EUR 6.3 million EU grant to develop integrated approaches for personalized cancer treatment 54

Apr 21, 2017: New study with Philips Trilogy reveals payers and hospitals can save millions in readmission costs, hospitalization rates for COPD patients 55

Product News 57

Jun 09, 2017: Phillips Company Issues Voluntary Worldwide Recall of All Topical Products Due to Concerns of Manufacturing Practices 57

Other Significant Developments 58

Oct 05, 2018: Philips launches Ambient Experience preparation & recovery bay to support patients and staff before and after medical procedures 58

Mar 19, 2018: Philips convenes the 2018 Annual General Meeting of Shareholders 59

Nov 02, 2017: Philips provides update on the company strategy and performance at Capital Markets Day in New York 60

Sep 14, 2017: Philips reaffirms commitment to patient safety by joining coalition to advance quality and safety in healthcare 61

Appendix 62

Methodology 62

About GlobalData 62

Contact Us 62

Disclaimer 62


List Of Figure

List of Figures

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Koninklijke Philips N.V., Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Key Facts, 2017 2

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Koninklijke Philips N.V., Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Koninklijke Philips N.V., Deals By Therapy Area, 2012 to YTD 2018 9

Koninklijke Philips N.V., Medical Devices Deals, 2012 to YTD 2018 10

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Biocartis Raises USD 40.5 Million In Series E Financing 13

NightBalance Raises Funds in Second Round of Financing 15

NightBalance Raises Funds Through Venture Financing 16

Biocartis Raises USD 44.7 Million In Series D Financing 17

Royal Philips and Memorial Sloan Kettering Cancer Center Enter into Research Agreement 19

Koninklijke Philips Enters into Agreement with Illumina 20

Ion Beam Applications Enters into Agreement with Philips Healthcare 21

Royal Philips Enters into Agreement with Universitaire Ziekenhuizen Leuven 22

Ion Beam Applications Enters into Co-Development Agreement with Royal Philips 23

Teva Pharma Industries to Form Joint Venture with Philips Medical Systems 24

Royal Philips Prices Public Offering of Notes Due 2019 for USD596.6 Million 25

Royal Philips Prices Public Offering of Notes Due 2023 for USD596.6 Million 26

Philips to Acquire Unisensor, Analytical Instrument Provider 27

Zambon Acquires Profile Pharma from Philips 28

Volcano Completes Acquisition Of Crux Biomedical, Developer Of Implantable Filter, For Up To USD 42.1 Million 29

Koninklijke Philips N.V., Key Competitors 32

Koninklijke Philips N.V., Key Employees 33

Koninklijke Philips N.V., Subsidiaries 34

Koninklijke Philips N.V., Joint Venture 37

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Koninklijke Philips N.V., Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Koninklijke Philips N.V. (Philips) is a diversified technology company develops and manufactures medical systems, consumer electronics and lighting products. The company offers patient care & clinical informatics, imaging systems, healthcare transformation services and home healthcare solutions. It also offers mother and child care, and oral healthcare products include male grooming and beauty products kitchen appliance, coffee, air, garment care, and floor care products and sleep, respiratory care, and respiratory drug delivery products. It also provides diagnostic x-ray, integrated clinical, magnetic resonance imaging, computed tomography, and molecular imaging solutions. The company provides health & wellness, personal care and domestic appliances. Philips offers consumer luminaires, lumileds, professional lighting solutions, light sources & electronics and automotive lighting. It has operational presence in both mature and growth geographies. The company caters to Healthcare, Consumer Life Style, and Lighting industries. Philips is headquartered in Amsterdam, the Netherlands.

Koninklijke Philips N.V. (PHIA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Koninklijke Philips N.V., Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Koninklijke Philips N.V., Medical Devices Deals, 2012 to YTD 2018 10

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deal Details 13

Venture Financing 13

Biocartis Raises USD 40.5 Million In Series E Financing 13

NightBalance Raises Funds in Second Round of Financing 15

NightBalance Raises Funds Through Venture Financing 16

Biocartis Raises USD 44.7 Million In Series D Financing 17

Partnerships 19

Royal Philips and Memorial Sloan Kettering Cancer Center Enter into Research Agreement 19

Koninklijke Philips Enters into Agreement with Illumina 20

Ion Beam Applications Enters into Agreement with Philips Healthcare 21

Royal Philips Enters into Agreement with Universitaire Ziekenhuizen Leuven 22

Ion Beam Applications Enters into Co-Development Agreement with Royal Philips 23

Teva Pharma Industries to Form Joint Venture with Philips Medical Systems 24

Debt Offering 25

Royal Philips Prices Public Offering of Notes Due 2019 for USD596.6 Million 25

Royal Philips Prices Public Offering of Notes Due 2023 for USD596.6 Million 26

Acquisition 27

Philips to Acquire Unisensor, Analytical Instrument Provider 27

Zambon Acquires Profile Pharma from Philips 28

Volcano Completes Acquisition Of Crux Biomedical, Developer Of Implantable Filter, For Up To USD 42.1 Million 29

Koninklijke Philips N.V.-Key Competitors 32

Koninklijke Philips N.V.-Key Employees 33

Koninklijke Philips N.V.-Locations And Subsidiaries 34

Head Office 34

Other Locations & Subsidiaries 34

Joint Venture 37

Recent Developments 38

Strategy And Business Planning 38

Aug 24, 2017: Governor Haslam, Commissioner Rolfe Announce Philips to Establish Business Center of Expertise in Middle Tennessee 38

Financial Announcements 39

Jul 23, 2018: Philips reports Second Quarter Results 2018 39

Apr 23, 2018: Philips First Quarter Results 2018 41

Jan 30, 2018: Philips' Fourth Quarter and Annual Results 2017 43

Oct 23, 2017: Philips' Third Quarter Results 2017 46

Jul 24, 2017: Philips' Second Quarter Results 2017 48

Corporate Communications 51

Oct 20, 2017: Extraordinary General Meeting of Shareholders appoints Marnix van Ginneken to Philips' Board of Management 51

Sep 18, 2017: Philips Steps Up Commitment to Ensuring Healthy Lives for All During United Nations General Assembly Week 52

Jul 20, 2017: Chief Business Leader of Philips' Personal Health businesses Pieter Nota to leave company 53

Government and Public Interest 54

Nov 23, 2017: Philips-led research consortium awarded EUR 6.3 million EU grant to develop integrated approaches for personalized cancer treatment 54

Apr 21, 2017: New study with Philips Trilogy reveals payers and hospitals can save millions in readmission costs, hospitalization rates for COPD patients 55

Product News 57

Jun 09, 2017: Phillips Company Issues Voluntary Worldwide Recall of All Topical Products Due to Concerns of Manufacturing Practices 57

Other Significant Developments 58

Oct 05, 2018: Philips launches Ambient Experience preparation & recovery bay to support patients and staff before and after medical procedures 58

Mar 19, 2018: Philips convenes the 2018 Annual General Meeting of Shareholders 59

Nov 02, 2017: Philips provides update on the company strategy and performance at Capital Markets Day in New York 60

Sep 14, 2017: Philips reaffirms commitment to patient safety by joining coalition to advance quality and safety in healthcare 61

Appendix 62

Methodology 62

About GlobalData 62

Contact Us 62

Disclaimer 62


List Of Figure

List of Figures

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Koninklijke Philips N.V., Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Key Facts, 2017 2

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Koninklijke Philips N.V., Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Koninklijke Philips N.V., Deals By Therapy Area, 2012 to YTD 2018 9

Koninklijke Philips N.V., Medical Devices Deals, 2012 to YTD 2018 10

Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Biocartis Raises USD 40.5 Million In Series E Financing 13

NightBalance Raises Funds in Second Round of Financing 15

NightBalance Raises Funds Through Venture Financing 16

Biocartis Raises USD 44.7 Million In Series D Financing 17

Royal Philips and Memorial Sloan Kettering Cancer Center Enter into Research Agreement 19

Koninklijke Philips Enters into Agreement with Illumina 20

Ion Beam Applications Enters into Agreement with Philips Healthcare 21

Royal Philips Enters into Agreement with Universitaire Ziekenhuizen Leuven 22

Ion Beam Applications Enters into Co-Development Agreement with Royal Philips 23

Teva Pharma Industries to Form Joint Venture with Philips Medical Systems 24

Royal Philips Prices Public Offering of Notes Due 2019 for USD596.6 Million 25

Royal Philips Prices Public Offering of Notes Due 2023 for USD596.6 Million 26

Philips to Acquire Unisensor, Analytical Instrument Provider 27

Zambon Acquires Profile Pharma from Philips 28

Volcano Completes Acquisition Of Crux Biomedical, Developer Of Implantable Filter, For Up To USD 42.1 Million 29

Koninklijke Philips N.V., Key Competitors 32

Koninklijke Philips N.V., Key Employees 33

Koninklijke Philips N.V., Subsidiaries 34

Koninklijke Philips N.V., Joint Venture 37

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Koninklijke Philips N.V., Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.